Cancer Stem Cells, Hypoxia and Metastasis

Seminars in Radiation Oncology

Volumn 19, Issue 2, 2009, Pages 106-111

  Hill, Richard P ^a,b   Marie Egyptienne, Delphine T ^a,b   Hedley, David W ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL INTERACTION; CELL LEVEL; CELL MIGRATION; EMBRYO DEVELOPMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION; METASTASIS; MICROENVIRONMENT; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GENE;

ANOXIA; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 60649097960     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2008.12.002     Document Type: Review

References (91)

1. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumors: Accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008) 755-768
2. Hill R.P., and Perris R. "Destemming" cancer stem cells. J Natl Cancer Inst 99 (2007) 1435-1440
3. Cairns R.A., Khokha R., and Hill R.P. Molecular mechanisms of tumor invasion and metastasis: An integrated view. Curr Mol Med 3 (2003) 659-671
4. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2 (2002) 563-572
5. Fidler I.J. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3 (2003) 453-458
6. Kiel M.J., and Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8 (2008) 290-301
7. Raaijmakers M.H., and Scadden D.T. Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr Opin Hematol 15 (2008) 301-306
8. Miele L., Golde T., and Osborne B. Notch signaling in cancer. Curr Mol Med 6 (2006) 905-918
9. Tung D.C., and Chao K.S. Targeting hedgehog in cancer stem cells: How a paradigm shift can improve treatment response. Future Oncol 3 (2007) 569-574
10. Katoh M. Wnt signaling in stem cell biology and regenerative medicine. Curr Drug Targets 9 (2008) 565-570
11. D'Souza B., Miyamoto A., and Weinmaster G. The many facets of Notch ligands. Oncogene 27 (2008) 5148-5167
12. Varjosalo M., and Taipale J. Hedgehog: Functions and mechanisms. Genes Dev 22 (2008) 2454-2472
13. Vaupel P., and Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 26 (2007) 225-239
14. Vaupel P., Kelleher D.K., and Hockel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 28 Suppl 8 (2001) 29-35
15. Lanzen J., Braun R.D., Klitzman B., et al. Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res 66 (2006) 2219-2223
16. Brurberg K.G., Gaustad J.V., Mollatt C.S., et al. Temporal heterogeneity in blood supply in human tumor xenografts. Neoplasia 10 (2008) 727-735
17. Brurberg K.G., Thuen M., Ruud E.B., et al. Fluctuations in pO2 in irradiated human melanoma xenografts. Radiat Res 165 (2006) 16-25
18. Cardenas-Navia L.I., Mace D., Richardson D.F., et al. The pervasive presence of fluctuating oxygenation in tumors. Cancer Res 68 (2008) 5812-5819
19. Lunt S.J., Chaudary N., and Hill R.P. The tumor microenvironment and metastatic disease. Jun 10, 2008 (2008) Jun 10, [E-pub ahead of print]
20. Gort E.H., Groot A.J., van der Wall E., et al. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 8 (2008) 60-67
21. Sullivan R., and Graham C.H. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 26 (2007) 319-331
22. Chan D.A., and Giaccia A.J. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26 (2007) 333-339
23. Harris A.L. Hypoxia-A key regulatory factor in tumor growth. Nat Rev Cancer 2 (2002) 38-47
24. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
25. Semenza G.L. Hypoxia and cancer. Cancer Metastasis Rev 26 (2007) 223-224
26. Maynard M.A., and Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci 64 (2007) 2170-2180
27. Mabjeesh N.J., and Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 22 (2007) 559-572
28. Raval R.R., Lau K.W., Tran M.G., et al. Contrasting properties of hypoxia-inducible factor-1 (HIF-1) and HIF-2 in Von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 25 (2005) 5675-5686
29. Liu Y.L., Yu J.M., Song X.R., et al. Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines. Cancer Biol Ther 5 (2006) 1320-1326
30. Winter S.C., Shah K.A., Han L., et al. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer 107 (2006) 757-766
31. Dayan F., Roux D., Brahimi-Horn M.C., et al. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Res 66 (2006) 3688-3698
32. Wouters B.G., and Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8 (2008) 851-864
33. Moeller B.J., Cao Y., Li C.Y., et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: Role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-441
34. Prabhakar N.R., Kumar G.K., Nanduri J., et al. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 9 (2007) 1397-1403
35. Ezashi T., Das P., and Roberts R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A 102 (2005) 4783-4788
36. Cipolleschi M.G., Dello Sbarba P., and Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82 (1993) 2031-2037
37. Parmar K., Mauch P., Vergilio R., et al. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 104 (2007) 5431-5436
38. Levesque J.P., Winkler I.G., Hendy J., et al. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 25 (2007) 1954-1965
39. D'Ippolito G., Diabira S., Howard G.A., et al. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human Miami cells. Bone 39 (2006) 513-522
40. Grayson W.L., Zhao F., Izadpanah R., et al. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207 (2006) 331-339
41. Studer L., Csete M., Lee S.H., et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20 (2000) 7377-7383
42. Morrison S.J., Csete M., Groves A.K., et al. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci 20 (2000) 7370-7376
43. Morrison S.J., Perez S.E., Qiao Z., et al. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 101 (2000) 499-510
44. Lin Q., Lee Y.J., and Yun Z. Differentiation arrest by hypoxia. J Biol Chem 281 (2006) 30678-30683
45. Axelson H., Fredlund E., Ovenberger M., et al. Hypoxia-induced dedifferentiation of tumor cells-A mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16 (2005) 554-563
46. Das B., Tsuchida R., Malkin D., et al. Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26 (2008) 1818-1830
47. Platet N., Lin S.Y., Atifi M.E., et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett 258 (2007) 286-290
48. Barnhart B.C., and Simon M.C. Metastasis and stem cell pathways. Cancer Metastasis Rev 26 (2007) 261-271
49. Keith B., and Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 129 (2007) 465-472
50. Covello K.L., Kehler J., Yu H., et al. HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20 (2006) 557-570
51. Gidekel S., Pizov G., Bergman Y., et al. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4 (2003) 361-370
52. Nofziger D., Miyamoto A., Lyons K.M., et al. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126 (1999) 1689-1702
53. Wilson A., and Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 580 (2006) 2860-2868
54. Gustafsson M.V., Zheng X., Pereira K., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9 (2005) 617-628
55. Koshiji M., Kageyama Y., Pete E.A., et al. HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 23 (2004) 1949-1956
56. Gordan J.D., Bertout J.A., Hu C.J., et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11 (2007) 335-347
57. Meyer N., and Penn L.Z. Reflecting on 25 years with MYC. Nat Rev Cancer 8 (2008) 976-990
58. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
59. Maherali N., Sridharan R., Xie W., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell stem. Cell 1 (2007) 55-70
60. Mani S.A., Guo W., Liao M.J., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
61. Ben-Porath I., Thomson M.W., Carey V.J., et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40 (2008) 499-507
62. Morel A.P., Lievre M., Thomas C., et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3 (2008) e2888
63. Weinberg R.A. Twisted epithelial-mesenchymal transition blocks senescence. Nat Cell Biol 10 (2008) 1021-1023
64. Gavert N., and Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 14 (2008) 199-209
65. Guarino M., Rubino B., and Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39 (2007) 305-318
66. Thompson E.W., and Williams E.D. EMT and MET in carcinoma-Clinical observations, regulatory pathways and new models. Clin Exp Metastasis 25 (2008) 591-592
67. Tse J.C., and Kalluri R. Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101 (2007) 816-829
68. Turley E.A., Veiseh M., Radisky D.C., et al. Mechanisms of disease: Epithelial-Mesenchymal transition-Does cellular plasticity fuel neoplastic progression?. Nat Clin Pract Oncol 5 (2008) 280-290
69. Berx G., et al. Pre-EMTing metastasis?: Recapitulation of morphogenetic processes in cancer. Clin Exp Metastasis 24 (2007) 587-597
70. Yang M.H., Wu M.Z., Chiou S.H., et al. Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10 (2008) 295-305
71. Sahlgren C., Gustafsson M.V., Jin S., et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 105 (2008) 6392-6397
72. Cannito S., Novo E., Compagnone A., et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29 (2008) 2267-2278
73. Cicchini C., Laudadio I., Citarella F., et al. TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314 (2008) 143-152
74. McLean G.W., Carragher N.O., Avizienyte E., et al. The role of focal-adhesion kinase in cancer-A new therapeutic opportunity. Nat Rev Cancer 5 (2005) 505-515
75. Avizienyte E., and Frame M.C. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17 (2005) 542-547
76. Canel M., Secades M., Garzon-Arango M., et al. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer 98 (2008) 1274-1284
77. Sawai H., Okada Y., Funahashi H., et al. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer 4 (2005) 37
78. Imai T., Horiuchi A., Wang C., et al. Hypoxia attenuates the expression of E-cadherin via upregulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163 (2003) 1437-1447
79. Esteban M.A., Tran M.G., Hartan S.K., et al. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res 66 (2006) 3567-3575
80. Krishnamachary B., Zagzag D., Nagasawa H., et al. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66 (2006) 2725-2731
81. Pham N.A., Magalhaes J.M., Do T., et al. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. Int J Cancer 124 (2008) 280-286
82. Kaplan R.N., Psaila B., and Lyden D. Bone marrow cells in the 'pre-metastatic niche': Within bone and beyond. Cancer Metastasis Rev 25 (2006) 521-529
83. Kaplan R.N., Rafii S., and Lyden D. Preparing the 'soil': The premetastatic niche. Cancer Res 66 (2006) 11089-11093
84. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
85. Wels J., Kaplan R.N., Rafii S., et al. Migratory neighbors and distant invaders: Tumor-associated niche cells. Genes Dev 22 (2008) 559-574
86. Hiratsuka S., Watanabe A., Aburatani H., et al. Tumor-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8 (2006) 1369-1375
87. Ceradini D.J., and Gurtner G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15 (2005) 57-63
88. Staller P., Sulitkova J., Lisztwan J., et al. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumor suppressor pVHL. Nature 425 (2003) 307-311
89. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
90. Kucia M., Reca R., Miekus K., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
91. Zipori D. The nature of stem cells: State rather than entity. Nat Rev Genet 5 (2004) 873-878